# Betoptic S

NDC: 0078-0729
Generic name: betaxolol hydrochloride
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 19960115
Marketing ended: 20261130
FDA application: NDA019845

## Active ingredients

- BETAXOLOL HYDROCHLORIDE: 2.8 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0729"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0729
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=905ba189-456c-4aa4-8231-39a971374ad8